PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 105 filers reported holding PULMONX CORP in Q3 2022. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,000 | +14.6% | 4,592 | +48.5% | 0.00% | – |
| Q2 2023 | $41,000 | +95.2% | 3,092 | +61.3% | 0.00% | – |
| Q1 2023 | $21,000 | -59.6% | 1,917 | -69.1% | 0.00% | – |
| Q4 2022 | $52,000 | +642.9% | 6,198 | +1386.3% | 0.00% | – |
| Q3 2022 | $7,000 | +133.3% | 417 | +117.2% | 0.00% | – |
| Q2 2022 | $3,000 | -92.5% | 192 | -88.0% | 0.00% | – |
| Q1 2022 | $40,000 | -77.4% | 1,605 | -70.9% | 0.00% | – |
| Q4 2021 | $177,000 | +90.3% | 5,517 | +114.3% | 0.00% | – |
| Q3 2021 | $93,000 | +14.8% | 2,575 | +40.0% | 0.00% | – |
| Q2 2021 | $81,000 | +102.5% | 1,839 | +113.1% | 0.00% | – |
| Q1 2021 | $40,000 | +48.1% | 863 | +119.0% | 0.00% | – |
| Q4 2020 | $27,000 | – | 394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |